| Trial ID: | L0630 |
| Source ID: | NCT02031770
|
| Associated Drug: |
Sodium Bicarbonate
|
| Title: |
Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02031770/results
|
| Conditions: |
Metabolic Acidosis|Chronic Kidney Disease
|
| Interventions: |
DRUG: Sodium bicarbonate|OTHER: Control
|
| Outcome Measures: |
Primary: Change in Brachial Artery Flow Mediated Dilation (FMD), The primary endpoint is change in brachial artery FMD between treatment and control conditions. Each treatment period is 6 weeks in duration with a 2 week washout period in between. Outcome measures will be repeated at the beginning and end of each period., 6 weeks and 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of Colorado, Denver | Collaborators: Denver Health and Hospital Authority
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2016-03
|
| Results First Posted: |
2020-09-22
|
| Last Update Posted: |
2020-09-22
|
| Locations: |
University of Colorado Denver, Aurora, Colorado, 80045, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02031770
|
